Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Lightsynq develops universal optical quantum interconnects that bridge the gap to large-scale quantum computers.
MIRIS provides spatial material and allows users to communicate with digital content.
Leuko Labs develops non-invasive white blood cell monitoring device.
DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.
NLX offers platform for automating customer experiences across channels with advanced AI and language models.
Fantix is an AI platform for privacy-first data science, synthetic data, and predictive analytics.
Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.
Grips Intelligence is a transaction Intelligence platform that delivers valuable insights into how the world buys products online.
Lindy Biosciences is a development-stage protein therapeutic formulations company.
Tethr operates as an AI-powered conversation intelligence platform.
Coagulo Medical Technologies is transforming medicine with the first portable and connected precision-medicine platform.
Obsidio is a medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels.
IAG Capital Partners has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IAG Capital Partners's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Machine Learning, Product Research. The firm invests across 26 different industry categories.
Among tracked funding rounds, MIRIS received $26.0M in a Seed round. IAG Capital Partners's total known invested capital is $1.3B.
IAG Capital Partners's average investment size is $21.8M across its portfolio of 60 companies.
Recent IAG Capital Partners portfolio additions include Lightsynq, MIRIS, Leuko, DeepCure, NLX. These companies were founded in 2020 or later.